NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
2.110
-0.230 (-9.83%)
At close: Feb 21, 2025, 4:00 PM
2.180
+0.070 (3.32%)
After-hours: Feb 21, 2025, 7:59 PM EST
Company Description
NewGenIvf Group Limited provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan.
Its services includes mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, mrt techniques, in-vitro fertilization /ICSI, hysteroscopy, semen analysis, TESE/TESA/PESA, embryo transfer, egg freezing, and chromosome screening, as well as surrogacy and ancillary caring services.
The company was founded in 2010 and is based in Central, Hong Kong.
NewGenIvf Group Limited
| Country | Hong Kong |
| Founded | 2011 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 70 |
| CEO | Wing Fung Siu |
Contact Details
Address: Pier 2, 1st Floor Central, 999077 Hong Kong | |
| Phone | 212-537-4406 |
| Website | newgenivf.com |
Stock Details
| Ticker Symbol | NIVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001981662 |
| ISIN Number | VGG0544E1051 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Wing Fung Siu | Chief Executive Officer |
| Fai Chung Ho | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 7, 2025 | 6-K/A | Filing |
| Jan 31, 2025 | 6-K | Report of foreign issuer |
| Jan 21, 2025 | 6-K | Report of foreign issuer |
| Dec 9, 2024 | EFFECT | Notice of Effectiveness |
| Dec 5, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Dec 5, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Dec 3, 2024 | 6-K | Report of foreign issuer |
| Dec 2, 2024 | UPLOAD | Filing |